Proteome Systems announced that its international partner, the Foundation for Innovative New Diagnostics (FIND), has signed off on the second Milestone in its Tuberculosis [TB] diagnostic program. Proteome Systems has discovered and patented TB proteins in human sputum and blood that can be used to diagnose active tuberculosis. There is currently no point-of-care [POC] test to detect TB in its active form. This recent milestone involved producing and using antibodies for the detection of these unique TB proteins in clinical samples.
FIND CEO Giorgio Roscigno said that reaching this second milestone is important particularly as it
coincides with World TB Day when partners worldwide are renewing their commitment to rally behind the new ten- year Global Plan to stop TB (2006-2015).